Mahalakshminarayana Taila is a powerful remedy for chronic diseases. It addresses diseases of Vata origin especially for pain in tissue elements, prolapse of lumbo-sacral region, stiffness of thigh muscles, neck rigidity, impairment/dysfunction of lower limbs, etc. It also promotes longevity, youthfulness and provides relief from emaciation, difficulty in swallowing food items, etc. It can induce apoptosis and prevent proliferation of harmful cells. Mahalakshminarayana Taila can help with Reticular Activating System (RAS) which has the unique phenomenon of selectively deactivating traumatic memories. The Endo Cannabinoid System is able to activate the immune system to locate and destroy insidious cells and tissues that could harm the effective functioning of the body. Inflammation, pain, nausea, fatigue, indigestion, malabsorption, sleeplessness are some of the key ailments that this product can help address. This product can deliver a powerful “Entourage Effect” which is the key benefit of using full spectrum extracts of multiple herbs wherein the thousands of active compounds as a whole is able to suppress the ill effects and amplify the positive effects of the individual compounds, a remarkable phenomenon which is not possible with a couple of synthetic or API compounds.
DISCLAIMER: Above descriptions are only for information purpose and not to be used for self- diagnosis.
ADDITIONAL INFORMATION
AYURVEDIC MEDICINE: Natural, herbal and non-GMO. No Preservatives, colouring agents or artificial flavours.
USAGE: Please consult physician for a prescription with the dosage that best suits your condition.
PRECAUTIONS & WARNINGS: Please avoid if pregnant, menstruating, or Low BP.
SIDE EFFECT / DRUG INTERACTIONS: No known complications in prescribed dosage.
STORAGE: Please keep bottle always tightly closed and stored in a cool, dark and dry place.
REFERENCE: Bruhad Nighantu Ratnakara, Vatavyadhi.
Caution: To be taken under medical supervision.
सावधान: चिकित्सकीय पर्यवेक्षण में ही लिया जाये।
Reviews
There are no reviews yet.